A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia
Clinical trial NCT01394991 · COMPLETED
Trial details
- NCT number
- NCT01394991
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-09-01
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.